TLP Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,100
Closed -$546K 443
2018
Q3
$546K Hold
6,100
0.86% 17
2018
Q2
$484K Buy
6,100
+100
+2% +$8.3K 0.74% 22
2018
Q1
$535K Buy
6,000
+150
+3% +$14.4K 0.37% 28
2017
Q4
$611K Buy
5,850
+2,683
+85% +$303K 0.42% 16
2017
Q3
$462K Buy
+3,167
New +$431K 0.29% 19
2016
Q3
Sell
-577
Closed -$57K 442
2016
Q2
$57K Buy
+577
New +$59.7K 0.04% 261

Other funds holding CELG

TLP Group's CELG Position: Q4 2018 in Review

TLP Group sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 6,100 shares — an estimated $546K sold.

TLP Group first reported a position in CELG in Q2 2016 and held it in 6 quarters. The position peaked at $611K in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • TLP Group reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 6,100 Celgene Corp shares in Q4 2018, an estimated $546K.
  • TLP Group first reported a position in Celgene Corp in Q2 2016 and held it in 6 quarters.
  • TLP Group's Celgene Corp position peaked at $611K in Q4 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.